John Garretson’s national patent litigation and counseling practice focuses on pharmaceuticals, biotech, medical devices and information technology. He has successfully handled cases in federal courts across the country, including more than 20 trials and appeals to the Federal Circuit, and has first-chaired cases for both domestic and international clients. He is a co-author of “U.S. Patent Litigation — 150 Questions and Answers,” published in Japan, and is a contributing author to Patent Resources Group’s “Pharma and Biotech Strategies — Hatch-Waxman and Litigation” (2011). He is frequently quoted in industry publications such as Bloomberg News, Law360 and Inside Counsel on intellectual property issues, and has served as a mediator chosen by the parties to help resolve ongoing litigation.